Co-Diagnostics
CODX
7 hedge funds and large institutions have $327K invested in Co-Diagnostics in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
40% more funds holding
Funds holding: 5 → 7 (+2)
0.01% less ownership
Funds ownership: 0.06% → 0.06% (-0.01%)
48% less capital invested
Capital invested by funds: $625K → $327K (-$298K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
+$35.8K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$20.8K |
| 3 |
AG
Advisor Group
Phoenix,
Arizona
|
+$6.53K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.27K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.09K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$98.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
HighTower Advisors
Chicago,
Illinois
| $138K | +$35.8K | +548 | +21% |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $74K | -$98.5K | -1,508 | -47% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $70K | – | – | – |
|
|
4
Citadel Advisors
Miami,
Florida
| $34K | +$20.8K | +318 | +69% |
|
|
5
UBS Group
Zurich,
Switzerland
| $7K | +$3.27K | +50 | +50% |
|
|
AG
6
Advisor Group
Phoenix,
Arizona
| $4K | +$6.53K | +100 | New |
|
|
7
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | +$2.09K | +32 | New |
|
CODX Hedge Fund Activity: Q4 2018 in Review
7 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q4 2018, worth a combined $327K — down 48% from $625K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CODX positions and 0 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was HighTower Advisors, adding an estimated $35.8K. The largest seller was Vanguard Group, cutting an estimated $98.5K.
- 7 institutional investors held Co-Diagnostics (CODX) as of Q4 2018, up from 5 in Q3 2018.
- Funds reported $327K of Co-Diagnostics stock for Q4 2018, down 48% quarter-over-quarter.
- 2 funds opened new Co-Diagnostics positions in Q4 2018 and 0 closed out, a net change of +2 holders.
- The largest Co-Diagnostics buyer in Q4 2018 was HighTower Advisors, an estimated $35.8K added.
- The largest Co-Diagnostics seller in Q4 2018 was Vanguard Group, an estimated $98.5K sold.
Based on aggregated 13F filings for Q4 2018.